Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 10, 2013
Effect of lovastatin on coxsackievirus B3 infection in human endothelial cellsBianca Werner, Sven Dittmann, Carsten Funke, et al.
The Journal of General Virology|April 16, 2010
Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cellsCarsten Funke, Martin Farr, Bianca Werner, et al.
Plos One|November 5, 2021
Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, GermanyDelphina Gomes, Andreas Beyerlein, Katharina Katz, et al.
Vaccines|January 18, 2020
Modulation of Vaccine-Induced HIV-1-Specific Immune Responses by Co-Electroporation of PD-L1 Encoding DNAPierre Tannig, Antonia Sophia Peter, Dennis Lapuente, et al.
BMC Infectious Diseases|June 1, 2022
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort studyLisette Warkentin, Nikoletta Zeschick, Thomas Kühlein, et al.
BMC Medicine|June 20, 2023
Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort studyLisette Warkentin, Felix Werner, Nikoletta Zeschick, et al.
Journal of Medicinal Chemistry|July 16, 2026
Structure-Based Adaptation of a SARS-CoV-2 Neutralizing Peptide to New Virus VariantsNina Raasch, Lucas Weißenborn, Elie Richel, et al.
Nanomaterials (Basel, Switzerland)|October 2, 2019
Calcium Phosphate Nanoparticle-Based Vaccines as a Platform for Improvement of HIV-1 Env Antibody Responses by Intrastructural HelpDominik Damm, Leonardo Rojas-Sánchez, Hannah Theobald, et al.
International Journal of Molecular Sciences|June 10, 2022
Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing MiniproteinLucas Weißenborn, Elie Richel, Helena Hüseman, et al.
BMC Medicine|September 19, 2023
Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort studyFelix Werner, Nikoletta Zeschick, Thomas Kühlein, et al.
Pageof 10